Skip to content

Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD

Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD: a fMRI-based Single-center, Randomized, Controlled, Assessor-blinded Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05516680
Enrollment
64
Registered
2022-08-25
Start date
2022-10-22
Completion date
2025-08-31
Last updated
2023-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Post-stroke Depression

Brief summary

Introduction: Post-stroke depression (PSD) is the most common mental complication after stroke and has a serious impact on functional outcomes and quality of life. Antidepressants are the first-line treatment for PSD, but many reported side effects remain. Clinical research and practice guidelines have shown that electro-acupuncture and rTMS have a positive effect on PSD. This trial aims to study the efficacy and safety of electro-acupuncture and a modern MRI-navigated rTMS for PSD and to explore its fMRI-based central mechanism on depression. It is hypothesized that electro-acupuncture and MRI-navigated rTMS treatment improves depressive symptoms, neuro-patho-physiological behaviors, quality of life and central response in PSD. Methods: In this randomized, controlled, assessors-blinded trial, sixty-four patients with PSD will be randomly allocated into the experiment group (n=32) or control group(n=32) . The experiment group will receive electro-acupuncture and MRI-navigated rTMS, and the control group will receive MRI-navigated rTMS treatment, in 12-20 sessions over 4 weeks. In addition, ten healthy people for fMRI scanning will be recruited as a healthy control group without any intervention. The primary outcome is the change from baseline in the Hamilton Depression Scale-24 items (HAMD-24) scores at week 4. The primary analysis of central mechanism mainly involves cortical morphology, local spontaneous brain activity, and default mode network (DMN) functional connectivity based on fMRI at 0-wk and 4-wk. Secondary outcomes include the neuro-patho-physiological and quality of life changes in cortical excitability with motor evoked potential test(MEP), National Institutes of Health Stroke Scale(NIHSS), EuroQol Five Dimensions Questionnaire(EQ-5D) Scale, Modified Barthel Index(MBI) Scale and Short Form-Health Scale of Traditional Chinese Medicine(SF-HSTCM). Additional indicators include the Acceptability Questionnaire and Health Economics Evaluation (cost-effectiveness analysis) to assess acceptability and economic practicality of the treatment in study. Outcomes are assessed at baseline and post intervention. Discussion: Electro-acupuncture and MRI-navigated rTMS therapy could become an alternative treatment for PSD, and it is expected that this trial will provide reliable clinical evidence and potential effect mechanism for the future use of electro-acupuncture and MRI-navigated rTMS for PSD.

Interventions

DEVICEelectro-acupuncture

Acupoints consist of Neiguan (PC6, bilateral), Shuigou (GV26), Sanyinjiao (SP6, affected side), Yintang (EX-HN3), Shangxing (GV23), Baihui (GV20), and Sishencong (EX-HN1). Disposable stainless-steel needles (0.25mm× 40 mm)will be used. After skin disinfection, the acupuncturists will twist and thrust the needle handles to achieve the sensation of achiness, heaviness, and numbness (known as de qi) at all acupoints. Following needle manipulations, electroacupuncture instruments(SDZ-V) will be used to attached the needle handles at EX-HN3, GV23, GV20 and EX-HN1 with a dilatational wave of 5 \ 10 Hz and a current intensity of 1 \ 3 mA depending on the patient's tolerance. The needles will be removed after 30 minutes except for GV26 without needle retention. Participants will receive 12-20 electroacupuncture sessions over four weeks at a frequency of 3-5 times per week.

DEVICEMRI-navigated rTMS

MRI:All MRI scans were taken to acquire high-resolution T1-weighted anatomical images on the 3T MRI Scanner. Electromyography(EMG):Surface EMG was used to record MEPs from the abductor pollicis brevis for determining RMT of the non-lesioned motor cortex.A single TMS pulse was delivered to the location to identify the RMT,defined as the minimum intensity capable of evoking at least 5 MEPs of \>50 μV in 10 consecutive trials.MRI-navigated rTMS:Using BrainSight system,left DLPFC targeting was individualized by reconstructing MRI data into a 3-dimensional brain image for neuro-navigation. Left DLPFC localization was central middle frontal gyrus,between superior frontal sulcus and middle frontal sulcus based on T1-weighted anatomical images.Focal rTMS was administered using a Magstim Rapid 2 connected to Y125-round coil that was identical.rTMS was applied at 110% RMT to the left DLPFC.At each session,3000 pulses were applied at 10 Hz with a total of 12-20 rTMS sessions over a 4-week period.

Sponsors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion criteria for patients: * Meet the TCM and Western medicine diagnostic criteria for first onset stroke within 6 months; * Aged 40-75 years; * Right-handed; * Single infarct in basal ganglia (volume:3-5cm); * Motor evoked potential (MEP) could be recorded by bilateral primary motor cortex (M1) stimulating. * National Institutes of Health Stroke Scale (NIHSS) score \<6; * Hamilton Depression Scale-24 items (HAMD-24) score \> 8; * Clear consciousness, no hearing and visual impairment, and cooperative physical examination (Glasgow Coma Scale (GCS) score \> 8); * Complete the screening, and sign the informed consent form voluntarily. Inclusion criteria for healthy subjects: * Healthy subjects, aged 40-75 years; * Right-handed; * HAMD-24 score \< 8; * Sign the informed consent voluntarily.

Design outcomes

Primary

MeasureTime frameDescription
fMRI scan0 weekCortical morphology, local spontaneous brain activity, and default mode network (DMN) functional connectivity
Hamilton Depression Scale-24 items scoreschange from baseline to week 4Reduction rate

Secondary

MeasureTime frameDescription
National Institutes of Health Stroke Scale0 weekThe minimum and maximum values are 0 and 42 points, and higher scores mean a worse outcome.
Modified Barthel Index Scale0 weekThe minimum and maximum values are 0 and 100 points, and higher scores mean a better outcome.
Short Form-Health Scale of Traditional Chinese Medicine0 weekThe minimum and maximum values are 0 and 130 points, and higher scores mean a worse outcome.
EuroQol Five Dimensions Questionnaire Scale0 weekThe minimum and maximum values of utility index are -0.391 and 1 points, and higher scores mean a better outcome.
motor evoked potential test0 weekCortical excitability

Other

MeasureTime frameDescription
Acceptability Questionnaire4 weeksIt is involved three levels: fully accepted, acceptable and not acceptable. The acceptance rate is calculated by the number of fully accepted and acceptable subjects. And higher rate mean a better outcome.
Health Economics Evaluation4 weeksCost-effectiveness analysis

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026